Cargando…
Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study
Gliclazide (G) is an antidiabetic drug commonly used in type 2 diabetes. It has extrapancreatic hypoglycemic effects, which makes it a good candidate in type 1 diabetes (T1D). In previous studies, we have shown that a gliclazide-bile acid mixture exerted a hypoglycemic effect in a rat model of T1D....
Autores principales: | Mooranian, Armin, Negrulj, Rebecca, Chen-Tan, Nigel, Al-Sallami, Hesham S, Fang, Zhongxiang, Mukkur, Trilochan, Mikov, Momir, Golocorbin-Kon, Svetlana, Fakhoury, Marc, Arfuso, Frank, Al-Salami, Hani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122185/ https://www.ncbi.nlm.nih.gov/pubmed/25114507 http://dx.doi.org/10.2147/DDDT.S65396 |
Ejemplares similares
-
Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol
por: Mooranian, Armin, et al.
Publicado: (2014) -
Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics
por: Mooranian, Armin, et al.
Publicado: (2014) -
An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer
por: Mooranian, Armin, et al.
Publicado: (2014) -
Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat
por: Lalić-Popović, Mladena, et al.
Publicado: (2013) -
A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compounds
por: Mooranian, Armin, et al.
Publicado: (2020)